CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 170 enrolled
Drug / intervention
Project X 26ml +2 moredrug
Likely dose
Project X 26mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03817580
NCT03817580Phase 3Completed
CompareCT.gov

Comparative Study of Antimicrobial Effectiveness Evaluation of 26 ml Project X, 5.1 ml Project X and Prevantics® Maxi Swabstick Following ASTM E1173

Professional Disposables International, Inc.·interventional·Posted Jan 25, 2019·Updated Oct 22, 2021

In Brief

A Phase 3 clinical trial evaluating Project X 26ml, Project X 5.1ml, and 1 other intervention for Bacterial Microflora Reduction. Completed, enrolled 170 participants across 1 site.

Detailed Summary

Comparative Study of Antimicrobial Effectiveness Evaluation of 26 ml Project X, 5.1ml Project X and Prevantics® Maxi Swabstick following ASTM E1173 - Standard Test Method for Evaluation of Preoperative, Precatheterization, or Preinjection Skin Preparations, ASTM International, West Conshohocken, PA, 2015,

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBacterial Microflora Reduction
CountriesRomania
Collaborators--

Timeline

Phase 3CompletedFinished
20192020202120222023202420252026
First PostedJan 25, 2019
Enrollment StartFeb 18, 2019
Primary CompletionJun 4, 2019
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 7.4 years ago

Interventions

Project X 26mldrug

Application of antiseptic drug to the inguinal and abdomen areas of the subjects

Project X 5.1mldrug

Application of antiseptic drug to the inguinal and abdomen areas of the subjects

Prevantics Maxi Swabstickdrug

Application of antiseptic drug to the inguinal and abdomen areas of the subjects